Skip to content

Treatment for sciatica through nadi pariksha

â??Clinical Assessment of Dosha Predominance in Gridhrasi Using an Electronic Device Nadi Tarangini.â??

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019841
Enrollment
100
Registered
2019-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient between ages of 16 to 70 years of either gender with classical sign & symptoms of Gridhrasi. 2. Patient ready to give consent.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for trial/ consent. 2. Patients with severe renal and severe cardiac diseases. 3. Diabetics 4. Pregnant women 5. Malignancy and Tuberculosis of spine, after infectious condition of spine. 6. Patient who have lost the control on bladder and bowel. 7. Patients suffering from rheumatoid arthritis, gout and severe spinal trauma. 8. Patient with spinal implants. 9. Patient suffered from severe systemic disorder 10. Sciatica due to fracture of spine

Design outcomes

Primary

MeasureTime frame
1. To classify patients of Vata Pradhan and Vata-Kapha Pradhan Gridhrasi into other possible sub-groups of clinical importance. 2. To perform Dosha assessment through Nadi Pareeksha using Nadi Trangini device in the patients of Gridhrasi Timepoint: 2 WEEKS

Secondary

MeasureTime frame
to plan a rational ayurvedic treatment for GridhrasiTimepoint: 1 yr

Countries

India

Contacts

Public ContactDr Sanjeev Sharma

NATIONAL INSTITUTE OF AYURVEDA JAIPPUR,RAJASTHAN

profsanjeevhp@gmail.com9418079691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026